|
|
Antiaging Products and ServicesPublished by: BCC Research Published: Feb. 1, 2005 - 171 Pages Table of ContentsINTRODUCTION REASONS FOR THIS STUDY AND ITS IMPORTANCE OBJECTIVES OF THIS STUDY AND ITS CONTRIBUTION THE AUDIENCE FOR THIS REPORT SCOPE AND CONTENT OF THE REPORT METHODOLOGY AND INFORMATION SOURCES ANALYSTS CREDENTIALS RELATED BCC REPORTS BCC ON-LINE SERVICES DISCLAIMER SUMMARY Summary Table: MARKET FOR ANTI-AGING PRODUCTS AND SERVICES: CURRENT AND PROJECTED U.S. SALES BY SEGMENT, THROUGH 2009 ($ MILLIONS) Summary Figure: MARKET FOR ANTI-AGING PRODUCTS AND SERVICES: CURRENT AND PROJECTED U.S. SALES BY SEGMENT, 2003-2009 ($ MILLIONS) OVERVIEW OF FACTORS IMPACTING THE MARKET FOR ANTI-AGING PRODUCTS AND SERVICES DEMOGRAPHICS: THE AGING OF THE U.S. POPULATION Table 1 AGE STRUCTURE OF THE U.S. POPULATION, 1990-2020 (%) Table 2 SHARE OF OLDEST U.S. POPULATION BY AGE, 1990-2050 (%) Table 3 U.S. POPULATION AND GROWTH RATES BY AGE GROUPS, THROUGH 2020 (000s) SOCIAL ATTITUDES: "AGING" AND "YOUTH" IN THE CONTEXT OF CHANGING POPULATION STRUCTURE THE BOOMER GENERATION IS REDEFINING "OLD AGE" Changing Life Cycle and Approach to Retirement Financial Clout of the Boomer Generation Is Turning Older Consumers into Trendsetters Income Distribution Table 4 INCOME DISTRIBUTION BY AGE, U.S. POPULATION VS. OLDER AMERICANS, 2004 (% OF HOUSEHOLDS) Asset Levels Table 5 HOME OWNERSHIP AND ESTIMATED MEDIAN NET WORTH BY AGE GROUP, 2003 (% AND $) Other Financial Characteristics Table 6 SELECTED FINANCIAL CHARACTERISTICS OF OLDER HOUSEHOLDS, 50 TO 64 AND 65+, 2004 BETTER EDUCATED BOOMERS AND GENERATION X-ERS ARE WELL INFORMED ABOUT THE ISSUES RELATED TO WELLNESS AND AGING More In-Depth Information than Ever Before on Aging and Related Diseases Available to Consumers Aging-Related Organizations Table 7 MOST INFLUENTIAL AGING-RELATED AGENCIES AND ORGANIZATIONS Table 7 (CONTINUED) Table 7 (CONTINUED) Internet Access Perception of Aging and Anti-Aging Products and Services Table 8 PERCEPTIONS OF ANTI-AGING BEHAVIORS (%) Both "Healthspan" and Life Span Seen as Desirable Goals QUEST FOR YOUTH REMAINS AN IMPORTANT DRIVER OF DEMAND FOR APPEARANCE-RELATED PRODUCTS AND SERVICES IN ALL AGE GROUPS Youthful Looks Are Widely Perceived as Desirable in All Age Groups "Preventive Anti-Aging" Concept Is Driving the Use of Anti-Aging Cosmetics and Procedures at Younger Ages THE IMPACT OF HEALTH CARE STRUCTURE, DELIVERY AND PRICES LACK OF GERONTOLOGISTS AND SPECIALIZED GERIATRIC CARE GROWING SHARE OF OUT-OF-POCKET EXPENDITURES Growing Share of Out-of-Pocket …(Continued) SOARING PRICES AND PERCEIVED GAPS IN DELIVERY MISMATCH BETWEEN SCIENTIFIC ADVANCES IN THE FIELD OF AGING AND CONSUMER EXPECTATIONS SERIOUS RESEARCH IN THE FIELD OF AGING HAS STARTED ONLY RECENTLY Overview of the Most Influential Theories of Aging Table 9 CURRENT MOST INFLUENTIAL THEORIES OF AGING Controversy within Medical and Scientific Communities THE RIFT BETWEEN THE SCIENCE AND THE BUSINESS OF AGING THE COSTS OF STAYING YOUNG ARE HIGH Table 10 THE COSTS OF STAYING YOUNG: AVERAGE PRICES FOR SELECTED ANTI-AGING PRODUCTS AND SERVICES, 2004 ($) PRODUCTS TARGETED AT MEDICAL CONDITIONS ASSOCIATED WITH AGING DEFINITION OF THE MARKET SEGMENT TOTAL MARKET FOR PRODUCTS TARGETED AT MEDICAL CONDITIONS ASSOCIATED WITH AGING Table 11 U.S. MARKET FOR PRODUCTS TARGETED AT MEDICAL CONDITIONS ASSOCIATED WITH AGING BY CONDITION TYPE, THROUGH 2009 ($ MILLION) Figure 1 U.S. MARKET FOR PRODUCTS TARGETED AT MEDICAL CONDITIONS ASSOCIATED WITH AGING BY TYPE, 2004 (%) Figure 1 (CONTINUED) Table 12 TOP PHARMACEUTICAL COMPANIES: ANTI-AGING CATEGORY CONCENTRATION, 2004 Table 12 (CONTINUED) U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT CARDIOVASCULAR DISEASES Major Types of Cardiovascular Diseases and Treatments Targeted at Cardiovascular Problems Major Types of Cardiovascular…(Continued) U.S. Anti-Aging Market Targeted at Cardiovascular Diseases by Product Type Table 13 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT CARDIOVASCULAR DISEASES BY TYPE, 2003 AND 2004 ($ MILLION) Figure 2 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT CARDIOVASCULAR DISEASES BY TYPE, 2004 (%) Overview of the Supplements Sector Market Share by Company Figure 3 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING MARKET FOR CARDIOVASCULAR DISEASES, 2003 (%) Anti-Aging Drugs in Development for Cardiovascular Diseases Table 14 ANTI-AGING DRUGS IN DEVELOPMENT FOR CARDIOVASCULAR DISEASES BY CONDITION, 2003 (NUMBER) Table 15 ANTI-AGING DRUGS TARGETED AT CARDIOVASCULAR DISEASES IN PHASE III CLINICAL TRIALS, AWAITING APPROVAL AND RECENTLY APPROVED Table 15 (CONTINUED) U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT BONE AND JOINT DETERIORATION Bone and Joint Diseases Associated with Aging Market for Products Targeted at Bone and Joint Diseases by Product Type Table 16 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT BONE AND JOINT DETERIORATION BY TYPE, 2003-2004 ($ MILLION) Figure 4 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT BONE AND JOINT DETERIORATION BY TYPE, 2004 (%) Overview of the Supplement Sector Market Share by Company Figure 5 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING MARKET FOR BONE AND JOINT DETERIORATION, 2003 (%) Figure 5 (CONTINUED) Anti-Aging Drugs in Development for Bone and Joint Diseases Table 17 ANTI-AGING DRUGS IN DEVELOPMENT AND RECENTLY APPROVED FOR BONE AND JOINT DISEASES Table 17 (CONTINUED) Table 17 (CONTINUED) U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT SEXUAL DYSFUNCTION AND ENDOCRINE SYSTEM CHANGES Segmentation of Anti-Aging Market for Products Targeted at Sexual Dysfunction and Endocrine System Changes U.S. Anti-Aging Market for Products Targeted at Sexual Dysfunction and Endocrine System Changes by Product Type Table 18 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT SEXUAL DYSFUNCTION AND ENDOCRINE SYSTEM CHANGES BY TYPE, 2003-2004 ($ MILLION) Figure 6 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT SEXUAL DYSFUNCTION AND ENDOCRINE SYSTEM CHANGES BY TYPE, 2004 (%) Controversy Regarding All Types of HRT Controversy Regarding…(Continued) Overview of the Supplements Sector Market Share by Company Figure 7 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING MARKET FOR SEXUAL DYSFUNCTION AND ENDOCRINE SYSTEM CHANGES, 2003 (%) Figure 8 PROJECTED MARKET SHARE BY DRUG IN THE SEXUAL DYSFUNCTION/IMPOTENCE SEGMENT, 2004 (%) Anti-Aging Drugs in Development for Sexual Dysfunction and Endocrine System Changes Table 19 ANTI-AGING DRUGS IN DEVELOPMENT AND RECENTLY APPROVED FOR SEXUAL DYSFUNCTION AND ENDOCRINE SYSTEM CHANGES U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT COGNITIVE AND CNS DISORDERS Overview of Major Cognitive and CNS Disorders Associated with Aging Anti-Aging Market for Products Targeted at Cognitive and CNS Disorders by Product Type Table 20 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT COGNITIVE AND CNS DISORDERS, 2003 AND 2004 ($ MILLION) Figure 9 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT COGNITIVE AND CNS DISORDERS BY TYPE, 2004 (%) Figure 9 (CONTINUED) Overview of the Supplement Sector Market Share by Company Figure 10 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING MARKET FOR COGNITIVE AND CNS DISORDERS, 2003 (%) Anti-Aging Drugs in Development for Cognitive and CNS Disorders Table 21 ANTI-AGING DRUGS IN DEVELOPMENT AND RECENTLY APPROVED FOR COGNITIVE AND CNS DISORDERS Table 21 (CONTINUED) U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT EYE DISORDERS Major Eye Disorders Associated with Aging Market for Products Targeted at Eye Disorders by Product Type Table 22 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT EYE DISORDERS, 2003-2004 ($ MILLION) Figure 11 U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT EYE DISORDERS BY TYPE, 2004 (%) Overview of the Supplement Sector Market Share by Company Figure 12 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING MARKET FOR PRODUCTS TARGETED AT EYE DISORDERS, 2003 (%) Anti-Aging Drugs in Development and Recently Approved for Eye Disorders Table 23 ANTI-AGING DRUGS IN DEVELOPMENT AND RECENTLY APPROVED FOR EYE DISORDERS Table 23 (CONTINUED) ANTI-AGING APPEARANCE PRODUCTS AND SERVICES TOTAL MARKET FOR ANTI-AGING APPEARANCE PRODUCTS AND SERVICES Table 24 U.S. MARKET FOR ANTI-AGING APPEARANCE PRODUCTS AND SERVICES, THROUGH 2009 ($ MILLION) Figure 13 U.S. MARKET FOR ANTI-AGING APPEARANCE PRODUCTS AND SERVICES BY SECTOR, 2004 (%) ANTI-AGING COSMETICS AND COSMECEUTICALS Defining the Market for Anti-Aging Cosmetics and Cosmeceuticals Total Market for Anti-Aging Cosmetics and Cosmeceuticals Table 25 U.S. MARKET FOR ANTI-AGING COSMETICS AND COSMECEUTICALS BY CONDITION TYPE, THROUGH 2009 ($ MILLION) Figure 14 U.S. MARKET FOR ANTI-AGING COSMETICS AND COSMECEUTICALS BY SEGMENT, 2004 (%) U.S. Market for Anti-Aging Cosmetics and Cosmeceuticals by Channel Figure 15 U.S. MARKET FOR ANTI-AGING COSMETICS AND COSMECEUTICALS BY CHANNEL, 2004 (%) U.S. Market for Anti-Aging Skin Care by Channel Figure 16 U.S. MARKET FOR ANTI-AGING SKIN CARE BY CHANNEL, 2004 (%) Table 26 SALES OF ANTI-AGING SKIN CARE THROUGH DRUG STORES, 2000-2004 ($ MILLIONS) Table 27 SALES OF ANTI-AGING SKIN CARE THROUGH WAL-MART, 2000-2004 ($ MILLIONS AND % SHARE OF TOTAL SECTOR SALES) U.S. Market for Anti-Aging Hair Color Products by Channel Figure 17 U.S. MARKET FOR ANTI-AGING HAIR COLOR BY CHANNEL, 2004 (%) Table 28 SALES OF ANTI-AGING HAIR COLOR THROUGH WAL-MART, 2000-2004 ($ MILLION AND % SHARE OF TOTAL SECTOR SALES) U.S. Market for Hair Loss Products by Channel Figure 18 U.S. MARKET FOR HAIR LOSS PRODUCTS BY CHANNEL, 2004 (%) Table 29 SALES OF PRESCRIPTION HAIR LOSS PRODUCTS THROUGH DRUG STORES, 2000-2004 ($ MILLION) Figure 19 SALES OF PRESCRIPTION HAIR LOSS PRODUCTS THROUGH DRUG STORES, 2000-2004 ($ MILLION) Walmart Sales Table 30 SALES OF HAIR LOSS PRODUCTS THROUGH WAL-MART, 2000-2004 ($ MILLION AND % SHARE OF TOTAL SECTOR SALES) Market Share by Company Major Players in the Anti-Aging Skin Care Market Figure 20 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING SKIN CARE MARKET, 2004 (%) Major Players in the Anti-Aging Hair Color Market Figure 21 MARKET SHARE BY COMPANY IN THE U.S. ANTI-AGING HAIR COLOR MARKET, 2004 (%) Major Players in the Hair Loss Market Figure 22 MARKET SHARE BY COMPANY IN THE U.S. HAIR LOSS MARKET, 2004 (%) Trends in the Cosmetics and Cosmeceuticals Sector Anti-Aging Products Are Attracting a Younger Customer Base Blurring Boundaries between Mass and Prestige Products as Consumers Are Trading Up Blurring Boundaries between…(continued) Alternative Technologies Are Putting Pressure on the Anti-Aging Cosmeceuticals to Deliver Enhanced Performance Dermatology Products Prestige Products Mass Market Producers Genetics-Based Cosmetics-The Next Step? Crossover Products-Nutraceuticals/Cosmeceuticals Crossover Products-…(continued) Anti-Aging Makeup: Emerging Trend The Hair Care Category Has Not Addressed the Anti-Aging Issue to the Full Extent Hair Regrowth Category in Need of Innovation Hair Regrowth Category…(continued) ANTI-AGING COSMETIC PROCEDURES Total Market for Cosmetic Procedures Table 31 U.S. MARKET FOR ANTI-AGING COSMETIC PROCEDURES, THROUGH 2009 (NUMBER OF PROCEDURES) Table 32 U.S. MARKET FOR ANTI-AGING COSMETIC PROCEDURES, THROUGH 2009 ($ MILLIONS) Price Differential between Nonsurgical and Surgical Procedures Is Impacting the Structure of Demand Table 33 MEAN AND MEDIAN PRICES FOR SURGICAL AND NONSURGICAL ANTI-AGING COSMETIC PROCEDURES IN 2004 ($) Market for Anti-Aging Cosmetic Procedures by Type of Procedures Market for Anti-Aging Surgical Cosmetic Procedures Table 34 U.S. ANTI-AGING SURGICAL COSMETIC PROCEDURES MARKET BY TYPE, 2004 (NUMBER, $ MILLIONS AND % SHARE) Table 34 (CONTINUED) Number of Procedures Table 35 U.S. ANTI-AGING SURGICAL COSMETIC PROCEDURES BY TYPE, THROUGH 2009 (NUMBER) Table 35 (CONTINUED) Sales Table 36 ANTI-AGING SURGICAL COSMETIC PROCEDURES BY TYPE, THROUGH 2009 ($ MILLION) Market for Anti-Aging Nonsurgical Cosmetic Procedures Market for Anti-Aging…(continued) Table 37 ANTI-AGING NONSURGICAL COSMETIC PROCEDURES MARKET BY TYPE IN 2004 (NUMBER, $ MILLION AND % SHARE) Number of Procedures Table 38 ANTI-AGING NONSURGICAL COSMETIC PROCEDURES PRODUCTION BY TYPE, THROUGH 2009 (NUMBER OF PROCEDURES) Table 38 (CONTINUED) Sales Table 39 ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY TYPE, THROUGH 2009 ($ MILLIONS) Market for Anti-Aging Cosmetic Procedures by Age of Customer Market for Anti-Aging Surgical Cosmetic Procedures by Age Number of Procedures Figure 23 TOTAL U.S. MARKET FOR ANTI-AGING SURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2004 (% OF NUMBER PERFORMED) Sales Figure 24 TOTAL U.S. MARKET FOR ANTI-AGING SURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2004 (% OF DOLLAR VOLUME) Age Groups Table 40 ANTI-AGING SURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2004 (% SHARE) Table 41 ANTI-AGING SURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2000 (% SHARE) Average Annual Growth Rates Table 42 ANNUAL AVERAGE GROWTH RATES IN ANTI-AGING SURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2000-2004 (%) Market for Anti-Aging NonSurgical Cosmetic Procedures by Age Number of Procedures Figure 25 TOTAL U.S. MARKET FOR ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY AGE, 2004 (% OF NUMBER PERFORMED) Sales Figure 26 TOTAL U.S. MARKET FOR ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY AGE, 2004 (% OF DOLLAR VOLUME) Age Groups Table 43 ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY AGE GROUP IN 2004 (% SHARE) Table 44 ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2000 (% SHARE) Average Annual Growth Rates Table 45 ANNUAL AVERAGE GROWTH RATES IN ANTI-AGING NONSURGICAL COSMETIC PROCEDURES BY AGE GROUP, 2000-2004 (%) Trends in Anti-Aging Cosmetic Procedures NonSurgical Anti-Aging Procedures Are Leading in Growth At the Same Time, Interest in Surgical Procedures Remains Strong Due to the Promotion by the Media Botox™ Is Being Challenged by the New Fillers, which May Present New Opportunities for Complementary Procedures Development and Marketing of the More Advanced Cosmeceuticals Is Impacting the Sector Reducing Downtime after Procedures Will Become Even More Important in the Future Table 46 DURATION OF AND DOWNTIME AFTER NONSURGICAL ANTI-AGING COSMETIC PROCEDURES ANTI-AGING TECHNOLOGIES AND THEIR IMPACT ON THE MARKET FOR ANTI-AGING PRODUCTS AND SERVICES ANTI-AGING TECHNOLOGIES: MAJOR PITFALLS RESEARCH IN THE AREA OF ANTI-AGING COSMETICS FUNCTIONALITY REQUIREMENTS ARE INCREASING ALTERNATIVES TO COSMETIC PROCEDURES DELIVERY IS KEY TO STRONGER THERAPEUTIC EFFECTS NATURAL INGREDIENTS ARE SEEN AS DELIVERING IMPORTANT ANTI-AGING BENEFITS Anti-irritants Have Anti-aging Applications Soy-Derived Isoflavones Act to Prevent Loss of Elasticity and Wrinkle Formation THE PROMISE OF STEM CELLS IN "REGROWING" HAIR AND SKIN RESEARCH IN THE AREA OF ANTI-AGING DRUGS AND SUPPLEMENTS UNCOVERING THE MECHANISMS OF CALORIC RESTRICTION Uncovering The Mechanisms…(Continued) Sirtuins as Regulators of Aging OTHER MECHANISMS THAT INCREASE LIFE SPAN THE POTENTIAL OF ANTIOXIDANTS IS STILL UNCLEAR RELATION OF TELOMERES TO AGING THE PROMISE OF STEM CELLS PLAYERS IN THE AREA OF COMMERCIALIZATION OF ANTI-AGING TECHNOLOGIES Table 47 MOST SIGNIFICANT PLAYERS INVOLVED IN COMMERCIALIZING OF ANTI-AGING TECHNOLOGIES IN NORTH AMERICA Table 47 (CONTINUED) Table 47 (CONTINUED) Table 47 (CONTINUED) Table 47 (CONTINUED) PATENTS IN THE AREA OF ANTI-AGING RESEARCH Figure 27 SHARES OF U.S. PATENTS BY PRODUCT TYPE, 2000-2004 Figure 28 SHARES OF U.S. PATENTS BY COUNTRY, 2000-2004 Table 48 ASSIGNEES OF TWO OR MORE U.S. PATENTS IN THE ANTI-AGING AREA, 2000-2004 Table 49 MOST SIGNIFICANT PATENTS IN THE AREA OF ANTI-AGING RESEARCH, 2000-2004 Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) Table 49 (CONTINUED) COMMERCIAL POTENTIAL OF ANTI-AGING TECHNOLOGIES Table 50 MARKET FOR ANTI AGING PRODUCTS USING ADVANCED ANTI-AGING TECHNOLOGIES BY SEGMENT, THROUGH 2025 ($ Millions) REGULATORY ISSUES REGULATION OF COSMETICS OVERVIEW OF COSMETICS REGULATIONS ADMINISTERED BY FDA Regulation of Products that Are Both Cosmetics and Drugs ("Cosmeceuticals") Table 51 PRINCIPAL DIFFERENCES IN REGULATORY REQUIREMENTS AFFECTING COSMETICS AND DRUGS Labeling Requirements for Cosmetic Products REGULATION OF DRUGS DRUG DEVELOPMENT AND APPROVAL PROCESS Stage I-Discovery/Preclinical Testing Table 52 STAGE I OF DRUG DEVELOPMENT AND APPROVAL PROCESS DRUG DISCOVERY AND PRECLINICAL TESTING Stage II-Clinical Trials Table 53 STAGE II OF DRUG DEVELOPMENT AND APPROVAL PROCESS CLINICAL TRIALS Stage III-FDA Review/Approval Stage IV-Additional Postmarketing Testing Post-Approval Regulations of Drugs Approval Procedure and Regulations for Generic Drugs Approval Procedure and Regulations for OTC Drugs Drug Labeling Regulations REGULATION OF DIETARY SUPPLEMENTS DSHEA DSHEA (Continued) Labeling Requirements for Dietary Supplements Claims Allowed for Dietary Supplements Health Claims Nutrient Content Claims Structure/Function Claims REGULATORY CHALLENGES AND ISSUES RELATED TO SELLING ANTI-AGING PRODUCTS AND SERVICES CLASH BETWEEN THE CONSUMER-ORIENTED MARKETING APPROACH IN THE ANTI-AGING MARKET AND REGULATORY OVERSIGHT Concerns Regarding Regulations of Anti-Aging Cosmetics in the U.S. Concerns Regarding Regulation of Anti-Aging Dietary Supplements in the U.S. Concerns Regarding Regulation…(Continued) Concerns Regarding Regulation…(Continued) Concerns Regarding Regulation of Anti-Aging Drugs in the U.S. Direct-To-Consumer (DTC) Promotion Direct-To-Consumer (DTC) … (continued) Direct-To-Consumer (DTC) … (continued) CONCLUSION: OVERVIEW OF IMPORTANCE OF REGULATORY ISSUES IN THE ANTI-AGING MARKET Table 54 MAJOR REGULATORY ASPECTS AND THEIR IMPORTANCE IN THE ANTI-AGING CATEGORIES AbstractThe report contains: A full discussion of factors impacting the U.S. market for antiaging products and services; Analysis of products targeted at medical conditions associated with aging; Analysis of antiaging appearance products and services; Analysis of antiaging technologies and their impact on the market; Market forecasts for all categories through 2009; Overview of regulatory aspects.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||